Mark Romagnoli
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark Romagnoli.
Journal of Clinical Microbiology | 2010
Matthew Karafin; Mark Romagnoli; Doran L. Fink; Tracy Howard; Rachel E. Rau; Aaron M. Milstone; Karen C. Carroll
ABSTRACT Cupriavidus gilardii is a Gram-negative bacterium that has rarely been associated with human infections. We report a fatal case of sepsis caused by C. gilardii in a previously healthy 12-year-old female.
Journal of Clinical Microbiology | 2009
Wei Jiang; Sahibzada Abrar; Mark Romagnoli; Karen C. Carroll
ABSTRACT We describe two cases of Clostridium glycolicum wound infections in immunocompetent adults. The bacterium was identified by 16S rRNA gene sequencing. This is the third published report of the recovery of this organism from human clinical material and highlights the importance of the organism as a potential human pathogen. Our report extends the spectrum of the diseases caused by C. glycolicum.
Diagnostic Microbiology and Infectious Disease | 2008
Alexandra C. Hristov; Paul G. Auwaerter; Mark Romagnoli; Karen C. Carroll
We report the 1st case of Bordetella hinzii septicemia associated with Epstein-Barr virus viremia and lymphoma. B. hinzii identification necessitated cellular fatty acid analysis by gas-liquid chromatography and 16S rRNA gene sequencing. Isolates were resistant to many antimicrobials. Resistance and diagnostic challenges complicated management and contributed to mortality.
American Journal of Clinical Pathology | 2016
Nuntra Suwantarat; Chelsea Weik; Mark Romagnoli; Brandon C. Ellis; Nicole Kwiatkowski; Karen C. Carroll
BACKGROUND Corynebacterium species and gram-positive coryneform-like bacteria (coryneforms) are increasingly reported causes of opportunistic infections in immunocompromised patients. Biochemical identification methods for these bacteria are often inaccurate. We evaluated matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for routine Corynebacterium and coryneform identification. METHODS A total of 286 Corynebacterium species and coryneforms recovered from patients were identified by MALDI-TOF MS analysis using the Bruker Microflex instrument, Biotyper software version 3.0, and database version 3.1.66 (Bruker Daltonics, Billerica, MA) following formic acid-based, direct on-plate extraction. The spectral cutoff scores used for interpretation were 2.0 or more for species-level identification and 1.7 or more for genus level. Scores lower than 1.7 were considered as no reliable identification. The results were compared with API Coryne (bioMérieux, Durham, NC) and sequencing of 16S ribosomal RNA genes. RESULTS Of the 231 Corynebacterium (19 species), 99.6% were correctly identified to the genus level and 88.7% to the species level. Of the 55 coryneforms (14 genera), 90.9% were correctly identified to the genus level and 67.3% to the species level. API Coryne was able to identify 89.2% of Corynebacterium species (species level) and 63.6% of coryneforms (genus level). CONCLUSIONS Rapid on-plate testing yielded identification of more Corynebacterium species and related bacteria than biochemical methods.
Journal of Clinical Microbiology | 2016
Nuntra Suwantarat; Mark Romagnoli; Karen C. Carroll
A 47-year-old male presented with signs and symptoms of left lower lobe pneumonia. At that time, sputum culture revealed only normal respiratory flora. The patient received intravenous ceftriaxone and azithromycin during his hospitalization, and after his discharge, he completed a 7-day course of
Journal of Clinical Microbiology | 2015
Nuntra Suwantarat; Maureen Grundy; Mayer Rubin; Renee Harris; Jo Anne Miller; Mark Romagnoli; Ann Hanlon; Tsigereda Tekle; Brandon C. Ellis; Frank R. Witter; Karen C. Carroll
ABSTRACT During a 14-month period of using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) for group B streptococcus (GBS) identification, we recovered 32 (1%) Streptococcus pseudoporcinus isolates from 3,276 GBS screening cultures from female genital sources (25 isolates from pregnant women and 7 from nonpregnant women). An additional two S. pseudoporcinus isolates were identified from a urine culture and a posthysterectomy wound culture. These isolates were found to cross-react with three different GBS antigen agglutination kits, PathoDx (Remel) (93%), Prolex (Pro-Lab Diagnostics) (38%), and Streptex (Remel) (53%). New approaches to bacterial identification in routine clinical microbiology laboratories may affect the prevalence of S. pseudoporcinus.
Anaerobe | 2016
Meklit Workneh; Frances Wang; Mark Romagnoli; Patricia J. Simner; Karen C. Carroll
We report a case of bypass graft infection and bacteremia caused by Anaerostipes caccae. A review of the literature shows no reported human infection caused by this microorganism to date. The patient was initially treated with vancomycin and piperacillin-tazobactam on admission and with amoxicillin-clavulanate upon discharge. The slow-growing organism was subsequently found to be susceptible to metronidazole and ertapenem.
Diagnostic Microbiology and Infectious Disease | 2015
Nuntra Suwantarat; La’tonzia L. Adams; Mark Romagnoli; Karen C. Carroll
Herbaspirillum spp. are rare causes of human infections associated primarily with bacteremia in cancer patients. We report the first fatal case of bacteremia secondary to pneumonia caused by Herbaspirillum seropedicae in a 65-year-old man with end-stage renal disease and multiple myeloma.
Journal of Clinical Microbiology | 1998
Charles G. Thornton; Kerry M. MacLellan; Thomas L. Brink; Denise E. Lockwood; Mark Romagnoli; June Turner; William G. Merz; Richard S. Schwalbe; Marcia Moody; Yvonne Lue; Selvin Passen
Journal of Clinical Microbiology | 1999
G. Frank Holmes; Susan M. Harrington; Mark Romagnoli; William G. Merz